Macrolide resistance

B Weisblum1

  • 1Department of Pharmacology, University of Wisconsin Medical School, Madison, Wisconsin 53706, USA. weisblum@macc.wisc.edu

Insights

Bacteria have evolved resistance to macrolide antibiotics through four generations, with mechanisms changing from inducible to constitutive resistance and rRNA alterations. Understanding these resistance pathways is crucial for developing new antibiotics.

Area of Science:

  • Microbiology
  • Pharmacology
  • Molecular Biology

Background:

  • Macrolide antibiotics, starting with erythromycin in 1952, have undergone four generations of chemical evolution.
  • Early macrolides induced bacterial resistance, leading to the development of second and third generations with altered resistance profiles and improved pharmacokinetics.
  • Third-generation macrolides, used for infections like Helicobacter pylori and Mycobacterium tuberculosis, selected for intrinsically resistant strains with rRNA structural changes.

Purpose of the Study:

  • To review the biochemical and genetic mechanisms of bacterial resistance to the first three generations of macrolide antibiotics.
  • To explain the evolution of macrolide resistance, including inducible, constitutive, and rRNA-mediated mechanisms.
  • To provide insights into the development of resistance against macrolide antibiotics.

Main Methods:

  • Review of existing literature on macrolide antibiotic resistance.
  • Analysis of biochemical pathways involved in bacterial resistance.
  • Examination of genetic regulation mechanisms of resistance expression.

Main Results:

  • First-generation macrolides (erythromycin) induced resistance, which was overcome by second-generation macrolides.
  • Second-generation macrolides selected for constitutive resistance through target strain mutation.
  • Third-generation macrolides, with improved pharmacokinetics, led to intrinsically resistant strains with rRNA alterations, where low rRNA gene copy number facilitated resistance expression.

Conclusions:

  • Bacterial resistance to macrolides is a dynamic process involving diverse biochemical and genetic strategies.
  • Understanding the evolutionary trajectory of macrolide resistance is essential for guiding the development of effective antimicrobial therapies.
  • The emergence of resistance highlights the need for continued research into novel antibiotic classes and resistance-breaking strategies.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...